Intra-vitreal vials/implants

Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between January to April 2016.
Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known,  then regardless of reason for use.
  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total Vials / Implants          
Vials / Impants for Wet Age Related Macular Degeneration (wAMD)          

 

Please find below the number of intravitreal injections/implants supplied to patients under the care of Ophthalmology at the Royal Surrey County Hospital NHS Foundation Trust in the 4 months between January to April 2016 (i.e. 1st January to 30th April 2016). The indication for treatment is not recorded on the Trust pharmacy dispensing system so the data may, therefore, include patients who have been treated with these drugs for indications other than those listed in the request.

 

DRUG Jan-16 Feb-16 Mar-16 Apr-16
AFLIBERCEPT 40 mg per ml Intravitreal Injection 148 130 142 120
BEVACIZUMAB 1.25 mg in 0.05ml Intravitreal Injection 6 8 2 5
DEXAMETHASONE 0.7 mg Intravitreal Implant 10 9 14 7
FLUOCINOLONE ACETONIDE 190 micrograms Intravitreal Implant 2 1 1  
RANIBIZUMAB 0.5 mg Injection 119 84 61 84

©2017 Royal Surrey County Hospital

Log in with your credentials

Forgot your details?